Expanding Rapid Ascertainment Networks of Schizophrenia Families in Taiwan
S-TOGET
2 other identifiers
observational
1,050
1 country
1
Brief Summary
This proposal responds to Request for Applications RFA ( Rapid Founding Award)-MH ( Mental Health)-08-131, which seeks applications that propose to enrich pre-existing resources for schizophrenia in the NIMH ( National Institute of Mental Health) Human Genetics Initiative and to apply genomic methods to further our understanding of the molecular etiology of the disorder. The overarching aims of this proposal are to quickly and cost-effectively ascertain a large sample of trio families affected by schizophrenia, and to discover causal variants for the disorder in the first family-based genome-wide association study (GWAS) of the disorder. In Taiwan, there is no such kind of policy to support this kind of GWAS study as it is a very expensive study, including collecting large family samples and genome-wide SNP scanning. We, thus, collaborate with Professor Ming T, Tsuang and his extended subcontracted researchers to apply for this project. We, the research team in Taiwan, will collect 3800 trio families (11400 subjects) of schizophrenia. In our recently completed NIMH-funded Genetic Linkage Study of Schizophrenia (R01MH059624; USA PI: Ming T. Tsuang; Taiwan PI: Hai-Gwo Hwu), the investigators established a large and efficient ascertainment network and infrastructure in Taiwan, which will again be utilized and expanded in the proposed study. Through additional ascertainment within this framework, the investigators will collect an aggregate sample with adequate power for detecting in a GWAS those variants that make even small contributions to the risk for the disorder. The investigators will meet the overarching goals of this project by accomplishing several Specific Aims, as follows:
- 1.Rapidly ascertain schizophrenia trio families from ten Taiwanese clinical ascertainment sites;
- 2.Supplement NIMH Genetics Initiative collections by sending all clinical data and biomaterials to the appropriate repositories;
- 3.Assess the association of schizophrenia with a genome-wide panel of single-nucleotide polymorphisms (SNPs) and their constituent haplotypes;
- 4.Analyze quantitative schizophrenia phenotypes such as age at onset ;
- 5.Perform a genome-wide survey for copy-number variations related to schizophrenia;
- 6.Test for gene-gene interactions (epistasis); and
- 7.Test for gene-environment interactions, such as the well-established effect of season of birth.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2009
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2009
CompletedFirst Submitted
Initial submission to the registry
February 25, 2010
CompletedFirst Posted
Study publicly available on registry
March 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedFebruary 8, 2021
February 1, 2021
4.4 years
February 25, 2010
February 3, 2021
Conditions
Keywords
Eligibility Criteria
schizophrenia Han Chinese Population one sibling with his/her parents
You may qualify if:
- Schizophrenia
- Trio families (a proband's parents should be recruited)
You may not qualify if:
- One or both parents of a proband was not alive
- with mental retardation
- with epilepsy
- with alcohol or substance abuse
- with other organic brain syndromes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, 10002, Taiwan
Biospecimen
Whole blood.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hai-Gwo Hwu, Professor
College of Medicine, National Taiwan University
Study Design
- Study Type
- observational
- Observational Model
- FAMILY BASED
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 25, 2010
First Posted
March 1, 2010
Study Start
July 1, 2009
Primary Completion
December 1, 2013
Study Completion
December 1, 2013
Last Updated
February 8, 2021
Record last verified: 2021-02